Migratory Engineering of T Cells for Cancer Therapy

Adoptive cell therapy (ACT) and chimeric antigen receptor (CAR) T cell therapy in particular represents an adaptive, yet versatile strategy for cancer treatment. Convincing results in the treatment of hematological malignancies have led to FDA approval for several CAR T cell therapies in defined ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaelides, Stefanos, Obeck, Hannah, Kechur, Daryna, Endres, Stefan, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692862/
https://www.ncbi.nlm.nih.gov/pubmed/36366354
http://dx.doi.org/10.3390/vaccines10111845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692862/
https://www.ncbi.nlm.nih.gov/pubmed/36366354
http://dx.doi.org/10.3390/vaccines10111845

Ejemplares similares